• Support
  • Contact Us
  • Corporate website
  • Customer Care
  • Training

  • ScienceWatch Home
  • Inside This Month...
  • Interviews

Featured Interviews
Author Commentaries
Institutional Interviews
Journal Interviews
Podcasts

  • Analyses

Featured Analyses
What's Hot In...
Special Topics

  • Data & Rankings

Sci-Bytes
Fast Breaking Papers
New Hot Papers
Emerging Research Fronts
Fast Moving Fronts
Corporate Research Fronts
Research Front Maps
Current Classics
Top Topics
Rising Stars
New Entrants
Country Profiles

  • About Science Watch

Methodology
Archives
Contact Us
RSS Feeds

 ScienceWatch

2008 : August - Fast Breaking Papers : Paul Kleihues

FAST BREAKING PAPERS - 2008

August 2008 Download this article
 
Paul Kleihues talks with ScienceWatch.com and answers a few questions about this month's Fast Breaking Paper in the field of Neuroscience & Behavior.
Kleihues Article Title: The 2007 WHO classification of tumours of the central nervous system
Authors: Louis, DN;Ohgaki, H;Wiestler, OD;Cavenee, WK;Burger, PC;Jouvet, A;Scheithauer, BW;Kleihues, P
Journal: ACTA NEUROPATHOL
Volume: 114
Issue: 2
Page: 97-109
Year: AUG 2007
* Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland.
* Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland.
(addresses have been truncated)

Why do you think your paper is highly cited?

The reason for the popularity of this article is not due to scientific novelty but rather to its usefulness for the cancer research and clinical oncology communities.

Would you summarize the significance of your paper in layman's terms?

It summarizes the current status of brain tumour diagnosis, with major emphasis on surgical pathology and genetic profiles. It contains a concise description of new tumor entities contained in the 4th edition of the WHO Classification of Tumours of the Central Nervous System, published by the International Agency for Research on Cancer (IARC) in 2007.

This book series was initiated by the World Health Organization (WHO) in 1957 and has achieved its major goal: to establish a classification and grading of human tumors that is accepted and used worldwide. Without clearly defined clinical and histopathological diagnostic criteria and, more recently, genetic and expression profiles, epidemiological studies and clinical trials would be difficult to conduct and would not be comparable among different centers, countries, and world regions.

The book is also essential for cancer registries as it forms the basis for histologically and genetically stratified population-based data on incidence, mortality, and survival rates of human tumors.

How did you become involved in this research, and which future trends do you envision in brain tumor research?

I have been scientifically interested in brain tumors throughout my professional career and I was Editor of the 2nd (1993) and 3rd (2000) Editions of the WHO Classification. Future research on brain tumor diagnosis will include genetic and expression profiles of individual tumors since this will form the basis for personalized treatment with novel targeted therapies. We anticipate that this will lead to an improvement of the prognosis of patients with malignant brain tumors, which is currently still very poor.

Professor Paul Kleihues, M.D.
Department of Pathology
University Hospital Zurich
Zurich, Switzerland

Keywords: who classification of tumours of the central nervous system, international agency for research on cancer, cancer research, clinical oncology, classification and grading of human tumors, clinical and histopathological diagnostic criteria, population-based data, incidence, mortality, survival rates, malignant brain tumors.

Download this article

back to top


2008 : August - Fast Breaking Papers : Paul Kleihues

  • © 2020 Clarivate
  • Careers
  • Copyright
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
Follow us Share to Twitter Share to LinkedIn Share to Facebook Share to Instagram
Previous
left arrow key
Next
right arrow key
Close Move